Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials

Overview of attention for article published in Breast Cancer Research and Treatment, July 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 30,200 followers.

5 or +5 years of adjuvant endocrine tx in breast cancer: a meta-analysis of published randomised trials http://t.co/EXohDn2F3y #springerlink

Compared with 5 years of tamoxifen,additional adjuvant endocrine therapy reduces risk of relapse of ER+ breast cancer http://t.co/DR5xmlIGq2

Förlängd endokrin behandling (efter 5 år) förbättrar överlevnaden hos kvinnor med bröstca. Metaanalys http://t.co/WH3mlCiukl

Compared with 5 years of tamoxifen,additional adjuvant endocrine therapy reduces risk of relapse of ER+ breast cancer http://t.co/DR5xmlIGq2